{"name":"Almirall, S.A.","slug":"almirall-sa","ticker":"","exchange":"","domain":"almirallsa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":13,"colorKey":"oncology","drugs":[{"name":"Tirbanibulin ointment 1%","genericName":"Tirbanibulin ointment 1%","slug":"tirbanibulin-ointment-1","indication":"Other","status":"marketed"},{"name":"Experimental: LAS 41004 dosage 1","genericName":"Experimental: LAS 41004 dosage 1","slug":"experimental-las-41004-dosage-1","indication":"Other","status":"phase_2"},{"name":"LAS41004 IMP3","genericName":"LAS41004 IMP3","slug":"las41004-imp3","indication":"Other","status":"phase_1"},{"name":"LAD106","genericName":"LAD106","slug":"lad106","indication":"Other","status":"phase_1"},{"name":"LAD191","genericName":"LAD191","slug":"lad191","indication":"Other","status":"phase_2"},{"name":"LAD603","genericName":"LAD603","slug":"lad603","indication":"Other","status":"phase_2"},{"name":"LAS189962","genericName":"LAS189962","slug":"las189962","indication":"Other","status":"phase_2"},{"name":"LAS41003","genericName":"LAS41003","slug":"las41003","indication":"Other","status":"phase_2"},{"name":"LAS41004","genericName":"LAS41004","slug":"las41004","indication":"Other","status":"phase_2"},{"name":"LAS41004 IMP2","genericName":"LAS41004 IMP2","slug":"las41004-imp2","indication":"Other","status":"phase_1"},{"name":"LAS41004 IMP4","genericName":"LAS41004 IMP4","slug":"las41004-imp4","indication":"Other","status":"phase_1"},{"name":"LAS41004 IMP5","genericName":"LAS41004 IMP5","slug":"las41004-imp5","indication":"Other","status":"phase_1"},{"name":"LAS41007 o.d.","genericName":"LAS41007 o.d.","slug":"las41007-o-d","indication":"Other","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"LAS106521","genericName":"LAS106521","slug":"las106521","indication":"Atopic dermatitis","status":"phase_3"},{"name":"LAS41005","genericName":"LAS41005","slug":"las41005","indication":"Atopic dermatitis","status":"phase_3"},{"name":"LASW1510","genericName":"LASW1510","slug":"lasw1510","indication":"Atopic dermatitis","status":"phase_3"},{"name":"LAS41007","genericName":"LAS41007","slug":"las41007","indication":"Atopic dermatitis","status":"phase_3"},{"name":"LAS41008","genericName":"LAS41008","slug":"las41008","indication":"Psoriasis","status":"phase_3"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"neuroscience","drugs":[{"name":"KX2-391 Ointment 1%","genericName":"KX2-391 Ointment 1%","slug":"kx2-391-ointment-1","indication":"Atopic dermatitis","status":"phase_3"},{"name":"dapsone gel","genericName":"dapsone gel","slug":"dapsone-gel","indication":"Acne vulgaris","status":"marketed"},{"name":"dapsone gel vehicle","genericName":"dapsone gel vehicle","slug":"dapsone-gel-vehicle","indication":"Acne vulgaris (topical gel formulation)","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"LASW1835","genericName":"LASW1835","slug":"lasw1835","indication":"Chronic obstructive pulmonary disease (COPD)","status":"phase_3"},{"name":"vehicle of LAS41007","genericName":"vehicle of LAS41007","slug":"vehicle-of-las41007","indication":"Chronic obstructive pulmonary disease (COPD)","status":"phase_3"}]}],"pipeline":[{"name":"Tirbanibulin ointment 1%","genericName":"Tirbanibulin ointment 1%","slug":"tirbanibulin-ointment-1","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Experimental: LAS 41004 dosage 1","genericName":"Experimental: LAS 41004 dosage 1","slug":"experimental-las-41004-dosage-1","phase":"phase_2","mechanism":"LAS 41004 is an investigational compound being developed by Almirall for dermatological or respiratory conditions, though its precise mechanism of action is not publicly disclosed.","indications":[],"catalyst":""},{"name":"LAS106521","genericName":"LAS106521","slug":"las106521","phase":"phase_3","mechanism":"LAS106521 is a selective phosphodiesterase 4 (PDE4) inhibitor that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Atopic dermatitis","Psoriasis"],"catalyst":""},{"name":"LAS41004 IMP3","genericName":"LAS41004 IMP3","slug":"las41004-imp3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41005","genericName":"LAS41005","slug":"las41005","phase":"phase_3","mechanism":"LAS41005 is a selective phosphodiesterase 4 (PDE4) inhibitor that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Atopic dermatitis","Psoriasis"],"catalyst":""},{"name":"LASW1510","genericName":"LASW1510","slug":"lasw1510","phase":"phase_3","mechanism":"LASW1510 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production in immune cells.","indications":["Atopic dermatitis","Psoriasis"],"catalyst":""},{"name":"LASW1835","genericName":"LASW1835","slug":"lasw1835","phase":"phase_3","mechanism":"LASW1835 is a selective inhibitor of phosphodiesterase 4 (PDE4) that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Chronic obstructive pulmonary disease (COPD)","Asthma"],"catalyst":""},{"name":"KX2-391 Ointment 1%","genericName":"KX2-391 Ointment 1%","slug":"kx2-391-ointment-1","phase":"phase_3","mechanism":"KX2-391 is a Src kinase inhibitor that reduces skin inflammation and keratinocyte proliferation in atopic dermatitis.","indications":["Atopic dermatitis"],"catalyst":""},{"name":"LAD106","genericName":"LAD106","slug":"lad106","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAD191","genericName":"LAD191","slug":"lad191","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAD603","genericName":"LAD603","slug":"lad603","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS189962","genericName":"LAS189962","slug":"las189962","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41003","genericName":"LAS41003","slug":"las41003","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41004","genericName":"LAS41004","slug":"las41004","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41004 IMP2","genericName":"LAS41004 IMP2","slug":"las41004-imp2","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41004 IMP4","genericName":"LAS41004 IMP4","slug":"las41004-imp4","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41004 IMP5","genericName":"LAS41004 IMP5","slug":"las41004-imp5","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41007","genericName":"LAS41007","slug":"las41007","phase":"phase_3","mechanism":"LAS41007 is a selective phosphodiesterase 4 (PDE4) inhibitor that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Atopic dermatitis","Psoriasis"],"catalyst":""},{"name":"LAS41007 o.d.","genericName":"LAS41007 o.d.","slug":"las41007-o-d","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LAS41008","genericName":"LAS41008","slug":"las41008","phase":"phase_3","mechanism":"LAS41008 is a selective phosphodiesterase 4 (PDE4) inhibitor that reduces inflammatory mediator production by increasing intracellular cAMP levels.","indications":["Psoriasis","Atopic dermatitis"],"catalyst":""},{"name":"dapsone gel","genericName":"dapsone gel","slug":"dapsone-gel","phase":"marketed","mechanism":"Small molecule","indications":["Acne vulgaris"],"catalyst":""},{"name":"dapsone gel vehicle","genericName":"dapsone gel vehicle","slug":"dapsone-gel-vehicle","phase":"phase_3","mechanism":"Dapsone is a sulfone antibiotic that inhibits bacterial dihydropteroate synthase and has anti-inflammatory properties, reducing neutrophil migration and reactive oxygen species production.","indications":["Acne vulgaris (topical gel formulation)"],"catalyst":""},{"name":"vehicle of LAS41007","genericName":"vehicle of LAS41007","slug":"vehicle-of-las41007","phase":"phase_3","mechanism":"LAS41007 is a small molecule inhibitor of the PDE4 enzyme.","indications":["Chronic obstructive pulmonary disease (COPD)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":23,"phaseCounts":{"marketed":2,"phase_2":7,"phase_3":9,"phase_1":5},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}